image
Healthcare - Biotechnology - NASDAQ - US
$ 2.9
-8.8 %
$ 5.02 M
Market Cap
-0.64
P/E
CASH FLOW STATEMENT
-10.4 M OPERATING CASH FLOW
70.95%
-1.08 M INVESTING CASH FLOW
-22.96%
3.67 M FINANCING CASH FLOW
218.33%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Exicure, Inc.
image
Net Income -16.9 M
Depreciation & Amortization 1.38 M
Capital Expenditures 0
Stock-Based Compensation 1.35 M
Change in Working Capital 914 K
Others 2.56 M
Free Cash Flow -10.4 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015
OPERATING CASH FLOW
Net Income (16.9) (2.6) (64.1) (24.7) (26.3) (22.4) (11.0) (16.9) (13.2)
Depreciation & Amortization 1.4 1.9 1.8 1.4 0.7 0.4 0.2 0.2 0.1
Deferred Income Tax 0 2 K 0.2 80 K (0.4) 0.3 (0.2) 67 K 0
Stock Based Compensation 1.3 1.4 2.9 2.2 1.8 1.8 1.5 0.7 0.4
Other Operating Activities 2.9 0.5 0.3 0.2 0.2 0.5 25 K 0.3 0.3
Change in Working Capital 0.9 (36.8) 24.1 (18.3) 25.2 11 K (10.4) 10.8 0.4
Cash From Operations (10.4) (35.7) (34.8) (39.3) 1.3 (19.5) (19.8) (5.0) (12.2)
INVESTING CASH FLOW
Capital Expenditures 0 10 K (1.0) (3.2) (1.1) 94 K (0.9) (0.4) 12 K
Other Items (1.1) 4.7 44.1 13.3 (62.4) 0 0 0 0
Cash From Investing Activities (1.1) 4.7 43.1 10.1 (63.4) 94 K (0.9) (0.4) 12 K
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0 0 0 0
Total Debt Repaid 0 (7.5) (10.0) 12.5 0 0 (1.0) 6.0 (0.1)
Dividends Paid 0 0 0 0 0 0 0 0 0
Other Financing Activities (1.8) (0.6) (0.4) (0.3) (6.4) (1.9) (3.7) 0.3 0
Cash From Financing Activities 3.7 (3.1) 1.1 15.1 84.3 20.1 26.9 6.3 19.6
CHANGE IN CASH
Net Change In Cash (7.8) (34.1) 9.4 (14.0) 22.2 0.5 6.1 0.9 7.4
FREE CASH FLOW
Free Cash Flow (10.4) (35.7) (35.8) (42.4) 0.2 (19.6) (20.7) (5.4) (12.2)